Stocks
Milestone Pharmaceuticals Inc.MIST
NASDAQHealthcareBiotechnology$1.70-2.86%
Focused on cardiovascular medicine, this biopharmaceutical company develops and commercializes treatments for heart conditions. Its lead product targets paroxysmal supraventricular tachycardia (PSVT), positioning it as a niche player in cardiac therapeutics. Investors monitor Milestone for clinical trial progress and potential FDA approvals in a specialized but high-need market segment.
Market Cap: $144.8M52W Range: $0.63 – $3.06
Congressional Interest in Milestone Pharmaceuticals Inc. (MIST)
No congressional trades have been disclosed for Milestone Pharmaceuticals Inc. (MIST) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading MIST?
No congressional trades found for this stock.